About LEAD Therapeutics
LEAD Therapeutics is a company based in San Bruno (United States) founded in 2006 was acquired by BioMarin Pharmaceutical in February 2010. It operates as a B2B. LEAD Therapeutics has raised $20 million across 2 funding rounds from investors including BioMarin Pharmaceutical, ProQuest Investments and Mustang Ventures. LEAD Therapeutics operates in a competitive market with competitors including Jazz Pharmaceuticals, C4 Therapeutics, Erasca, Revolution Medicines and MiRagen, among others.
- Headquarter San Bruno, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$20 M (USD)
in 2 rounds
-
Latest Funding Round
$3 M (USD), Series A
Jun 02, 2009
-
Investors
BioMarin Pharmaceutical
& 3 more
-
Employee Count
Employee Count
-
Acquired by
BioMarin Pharmaceutical
(Feb 04, 2010)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of LEAD Therapeutics
LEAD Therapeutics has successfully raised a total of $20M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $3 million completed in June 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $3.0M
-
First Round
First Round
(05 Nov 2007)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2009 | Amount | Series A - LEAD Therapeutics | Valuation |
investors |
|
| Nov, 2007 | Amount | Series A - LEAD Therapeutics | Valuation | ProQuest Investments , Pappas Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in LEAD Therapeutics
LEAD Therapeutics has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include BioMarin Pharmaceutical, ProQuest Investments and Mustang Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
VC firm focusing on life science sector
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by LEAD Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - LEAD Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Lead Therapeutics Comparisons
Competitors of LEAD Therapeutics
LEAD Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, C4 Therapeutics, Erasca, Revolution Medicines and MiRagen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cancer and rare diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Lead Therapeutics
Frequently Asked Questions about LEAD Therapeutics
When was LEAD Therapeutics founded?
LEAD Therapeutics was founded in 2006 and raised its 1st funding round 1 year after it was founded.
Where is LEAD Therapeutics located?
LEAD Therapeutics is headquartered in San Bruno, United States. It is registered at San Bruno, California, United States.
Is LEAD Therapeutics a funded company?
LEAD Therapeutics is a funded company, having raised a total of $20M across 2 funding rounds to date. The company's 1st funding round was a Series A of $17M, raised on Nov 05, 2007.
What does LEAD Therapeutics do?
LEAD Therapeutics drug discovery company developing therapeutics for cancer and infectious diseases treatment, focusing on providing healthcare solutions, advancing biotech innovations, drug discovery, and therapeutics development. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
Who are the top competitors of LEAD Therapeutics?
LEAD Therapeutics's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
Who are LEAD Therapeutics's investors?
LEAD Therapeutics has 4 investors. Key investors include BioMarin Pharmaceutical, ProQuest Investments, Mustang Ventures, and Pappas Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.